587 - MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer (ID 1246) - Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting

587 - MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer (ID 1246)

Molecular Targeting Probes - Radioactive & Nonradioactive -> Novel Radiochemistry & Chelation 587

587 - MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer (ID 1246)

Session Name

New Radiochemistry Methodology

Speakers

D. Abou

Authors

Presentation Topic

Molecular Targeting Probes - Radioactive & Nonradioactive -> Novel Radiochemistry & Chelation

Presentation Number

587

Previous Eposter

586 - A general ¹¹C-carboxylation approach mediated by fluoride-desilylation of organosilanes (ID 1239)

Next Eposters

588 - ¹⁷⁷Lu-EB-PSMA radioligand therapy with escalating doses in patients with metastatic castration-resistant prostate cancer (ID 771)

590 - Interim Assessment of Kidney Dosimetry and Pharmacokinetics in a Phase I Study of CTT1403, a novel ¹⁷⁷Lu-labeled Small Molecule Inhibitor of Prostate Specific Membrane Antigen (ID 773)

591 - Early prostate-specific antigen changes and clinical outcome following ¹⁷⁷Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer (ID 775)

593 - Predictive factors and prediction nomograms for LuPSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer: an international multicentre retrospective study (ID 777)

594 - Hematotoxicity after Radioligand Therapy with ¹⁷⁷Lu-PSMA-617 in Patients with Metastastic Prostate Cancer (ID 776)

595 - PSMA-ligand uptake in posttherapeutic ¹⁷⁷Lu-PSMA-617 scintigraphy to predict PSA response in patients with advanced mCRPC (ID 778)

598 - Bridging brain structural/functional connectivity and tau load in PSP: A [18F]PI-2620 PET/MRI study (ID 855)

600 - Interaction of Striatal Dopaminergic and Cholinergic Activity in Parkinson Disease: A Multimodal Imaging Study Based on ¹¹C-DTBZ and ¹⁸F- FEOBV PET Combined with Diffusion Tensor Imaging (ID 856)

602 - Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI (ID 857)

605 - The F18 FDG PET in breast carcinoma: Do patient characteristics, tumor histology or receptor status, have any impact on final staging? (ID 1040)